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ABSTRACT
Introduction: recent literature suggests that excessive use of blood cultures could prolong length of
stay and hospital costs. Moreover, low positive rates have been reported and positivity predictive scores
have recently been proposed. Methods: we conducted an observational prospective study in an Inter-
nal Medicine department of a university reference hospital analysing data from all patients to whom BC
was requested. Results: blood cultures were performed in 39.9% of 414 admissions. Patients with
blood cultures had higher length of stay and underwent more laboratory and imaging diagnostic tests.
Global positivity rate was of 7.5%. Patients fulfilling sepsis criteria had a higher positivity rate (21.7%)
and there were no positive blood cultures in patients without sepsis, namely in cases of isolated c-
reactive protein elevation, leucocytosis or fever. In addition, blood cultures results were not a determi-
nant of antibiotic adjust or de-escalation. Conclusions: our data suggest that the use of BC should be
done essentially in patients with sepsis criteria, reducing its unnecessary use, although more studies are
required to validate such practice.
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RESUMO
Introdução: o uso excessivo de hemoculturas tem sido associado a aumento do tempo de internamento
e de custos hospitalares. Adicionalmente, a literatura médica reporta taxas de positividade abaixo do
esperado, levando à criação de índices de predição de positividade. Métodos: estudo prospectivo ob-
servacional conduzido numa enfermaria de Medicina Interna de um hospital terciário, com recolha de
dados de todos os doentes a quem foram realizadas hemoculturas. Resultados: em 414 admissões,
foram colhidas hemoculturas em 39.9%. Os doentes a quem foram colhidas hemoculturas tiveram
maior tempo de internamento e mais exames laboratoriais e imagiológicos pedidos. 7,5% das hemocul-
turas foram positivas. Nos doentes com critérios de sepsis a taxa de positividade das hemoculturas foi
21,7% e não houve nenhuma hemocultura positiva em doente sem critérios de sépsis, nomeadamente
em doentes com elevação isolada de proteína c-reactiva, leucocitose ou febre. O resultado da hemocul-
tura não foi um determinante de de-escalação antibiótica. Conclusões: este estudo sugere que as
hemoculturas devem ser colhidas essencialmente em doentes com sepsis, podendo esta prática dimi-
nuir o seu sobreuso.
Palavras-chave: Hemocultura. Sepse. Medicina Interna. Microbiologia.
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Introduction
Blood cultures (BC) remain the gold standard
for the diagnosis of bloodstream infections. Positiv-
ity rates in unselected settings vary between 9 and
20% 1 and in patients fulfilling sepsis criteria can be
as high as 66%.2 Widespread use of BC has been
thoroughly debated.1,3. Recent papers suggest that
overuse of BC may be responsible for prolonging
hospital length of stay (LoS) and higher hospital
costs, without relevant impact on mortality.4 Direct
utility of BC when measured by therapeutic changes
based on its results is limited. According to a study
by Corbo et al in 355 admissions for community
acquired pneumonia, only in 5% of patients the
antibiotic was changed based on BC results.5
Simple measures can be taken in order to
optimize and rationalize the use of BC, namely adop-
tion of more strict criteria and emphasis on the im-
portance of microbiological analysis of other bio-
logical products like urine, sputum or pleural liq-
uid.6 Such practices can reduce BC use as much as
18% with important cost-reductions.6,7 Efforts have
been made for the development of BC positivity
prediction tools, either based on integrated scores
or focused on independent variables, but none has
achieved convincing results. Severity of infection still
seems to be the strongest predictor of BC positiv-
ity8,9 and more in depth information on BC overuse
and related clinical outcomes is crucial.
The aim of our study was to characterize in
the setting of an Internal Medicine Department the
use and burden of BC, its indications and utility and
its relationship with clinical outcome variables.
Material and Methods
An observational study was conducted with
information gathered from the clinical files of all dis-
charged patients during 3 months in an Internal
Medicine (IM) department of a university reference
hospital. The main variables included: age; gender;
presumptive diagnosis of infection; LoS; death;
number and result of BC; reason to order BC; clini-
cal setting (Emergency department [ED] vs ward)
and number of imagiologic and laboratory exams
ordered.
Data were collected using a structured form
designed specifically for this study. Blood cultures
were ordered according to medical criteria of the
attending physicians and there were no prestudy
orientations. Blood cultures were collected using the
standard microbial detection systems available in the
hospital (BacT/ALERT®, Biomérieux Inc. Durham,
N.C., EUA and BD BACTEC™, Becton, Dickinson and
Company, Shannon, Ireland) and no data was ob-
tained concerning the puncture-site or details of the
procedure.
The unit for analysis was the series of BC done
at the same time in a given patient (BC episode)
and not the individual BC. The following agents were
considered skin contaminants: Coagulase-negative
staphylococcus; Propionibacterium spp; Peptostrep-
tococcus spp; Corynebacterium spp; Micrococcus
spp. Blood culture episodes were classified as: i)
positive (at least two BC were positive for specimens
other than contaminants); ii) dubious (only one of
the BC had an isolated specimen or if the isolate was
one of the contaminants) and iii) negative (no speci-
mens identified).
The analysis was divided in subgroups: pa-
tients with/without infection, according to the diag-
nosis used by clinicians on medical files; patients
with/without BC and patients with/without sepsis
(Surviving Sepsis Campaign criteria applied by the
investigators.10
For statistical analysis SPSS version 21 (IBM
Inc.) was used. Discrete variables were described
with frequency tables and continuous variables with
means and standard deviations. Chi-square test was
used for bivariate analysis of dichotomous variables
and t-student test for continuous variables. Multi-
variate scenarios were analysed with binary logistic
regression. Results were considered significant for
p values below 0.05.
Results
A total of 414 admissions were analysed, with
a predominance of female gender (54.8%), mean
age of 73.0 years, mean LoS of 7,4 days (11.7 in
patients with BC) and an overall mortality rate of
9,4%. Blood cultures were performed in 165 ad-
missions (39.9%) and characterization of patients
is detailed in table 1. Mortality rate was consistently
more elevated in the patients in whom BC were
performed (17.0%). Subgroup analysis of patients
with and without infection criteria revealed higher
mortality in the first group (13,5% vs 4,7%). Higher
mortality in patients to whom BC were collected
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persists even in the group of patients without infec-
tion criteria, although less pronounced.
Out of 464 individual BC, 201 BC episodes were
considered. The mean number of BC per episode was
2.8 (range from 1 to 5) as described in table 2. The
group with BC had higher mean laboratory and
imagiologic exams ordered per patient (figure 1).
The global positivity rate of individual BC was
7.5%, but this value was significantly higher for BC
ordered in the ED (15.4%). All positive BC were
done in patients with sepsis criteria (table 3).
Blood culture usefulness was assessed using
as surrogate the change of antibiotic strategy as
consequence of BC result. From all the 201 BC epi-
sodes, antibiotic therapy was used in 172 at any
point of the episode. In 63 of those the antibiotic
was changed during hospital stay (31.3%), but only
21 (12.2%) were based on the BC result, even in
cases classified as dubious. Moreover, only in 10
cases there was antibiotic de-escalation based on
positive or dubious BC result, representing less than
5% of all the BC episodes.
Table 1: Comparison between patients with or without blood cultures.
Patients Patients
p-value p-value
All patients
without BC With BC
(bivariate (multivariate
Odds
analysis) analysis)
Ratio
Admissions 414 (100%) 249 (60.1%) 165 (39.9%)
Gender (female) 54.8% 57.8% 50.3% 0.93 0.384 N/S
Mean age (years) 73.0 71.9 74.6 0.003 0.578 N/S
LoS (mean days) 7.4 4.6 11.7 < 0.0001 < 0.0001 1.126
Mortality 33 11 (4.4%) 28 (17%) < 0.0001 < 0.0001 1.762
Mortality in patients with
presumptive infection 39 (13.5%) 4 (4.9%) 26 (18.3%) < 0.0001
Mortality in patients
without infection 9 (4.7%) 7 (4.2%) 2 (8.7%) < 0.0001
(Bivariate analysis with chi-square or t-student. Multivariate analysis [logistic regression] included gender, mean age, LoS, mortality and
presumptive infection for the dependent variable “performing blood culture” [n: total number of admissions; LoS: length of stay])
Table 2: Number of blood cultures drawn by episode of blood culture.
Number of episodes % of episodes
1 BC drawn 8 4.0
2 BC drawn 138 68.7
3 BC drawn 45 22.3
4 BC drawn 7 3.5
5 BC drawn 3 1.5
Total of BC drawn 201 100.0
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Figure 1: Laboratorial and imagiological exams per patient (means), according to BC ordering. (BC: Blood Culture; CT: Computorized
tomography)
Table 3: BC positivity according to setting and reason to order BC.
BC Positive BC Dubious BC Negative Total
Setting
ED 4 (15.4%) 2 (7.7%) 20 (76.9%) 26
Ward 11 (6.2%) 14 (7.9%) 152 (85.9%) 177
Reason to order BC
Sepsis 15 (8.6%) 13 (7.4%) 147 (84.0%) 175
Leucocytosis * 0 (0%) 0 (0%) 2 (100.0%) 2
CPR elevation * 0 (0%) 1 (6.3%) 15 (93.8%) 16
Fever * 0 (0%) 0 (0%) 7 (100.0%) 7
Control 0 (0%) 0 (0%) 3 (100.0%) 3
Total n (%) 15 (7.5%) 15 (7.5%) 171 (85.1%) 201
(BC: Blood culture; ED: Emergency department; CPR: C-reactive protein; * - patients without sepsis criteria)
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Discussion and Conclusion
These results on the use of BC in an Internal
Medicine ward reveal an excessive utilization and
moreover patients to whom BC are ordered have
higher LoS, more exams ordered and higher mor-
tality. Such results can not be directly attributed BC
ordering itself, but rather it is likely that clinicians
request of BC is related to the perception of unclear
diagnosis and to the severity of the underlying clini-
cal condition. This is particularly relevant in inter-
nal medicine wards, where multiple comorbidities,
severe infectious or non-infectious diseases and
complications during hospital stay are frequent.4,11,12
Our positivity rate is slightly lower than in
other series, which can be attributed to the several
BC performed in patients with low-severity infec-
tion, namely patients who do not meet sepsis crite-
ria.13 It has been proposed that severity of infec-
tion may be the best predictor of positivity of BC,
but the way to assess this remains controversial.14
Scores have attempted to predict positivity, since it
has been suggested that more precise criteria is
required.15 Shapiro et al,13 for instance, gathered
information concerning patients’ history, co-morbidi-
ties, physical examination and laboratory results that
were incorporated in a scale that determined with
high sensitivity which patients would benefit from
BC. However, our work suggests that the presence
of sepsis criteria might be the most relevant single
marker to reduce the number of BC, although this
requires further validation. Thus, improvement in
sepsis recognition may be more useful and simple
than the application of complex positivity predic-
tion scores.
The fact that in our series BC results were
not a determinant of antibiotic changes or de-esca-
lation indicates reduced usefulness of BC in this
setting. Blood cultures are known to have higher
positivity rates in patients with more severe infec-
tions and further studies may clarify in which situa-
tions BC do have a real impact on clinical outcomes.16
Site of infection may also play a role in deciding the
true value of performing a BC.17 More than deciding
in which patients to order a BC, our study helps to
select patients in whom BC could be avoided. As
previously described,18,19 many BC are ordered to
patients with simple elevation of C-reactive protein,
leucocytosis or fever, and in this setting positivity
rates can be extremely low, as documented in our
study, where there was no single positive BC in this
context.
The clinical setting has been proposed as a
relevant factor in excessive BC ordering,1,6 and in
fact it has been suggested that ED and night-shift
physicians ordered more tests in the assumption
that this was the expected practice by the attend-
ing physician. However, our study indicates that the
BC collected on ED had a higher positivity rate, sug-
gesting a good degree of appropriateness in this
setting. In any case, the emphasis should be put on
the importance of clinical recognition of sepsis, ir-
respective of clinical setting.
In conclusion, this study suggests that in pa-
tients admitted in an Internal Medicine wards it is
reasonable to perform BC essentially on patients
who fulfil current sepsis criteria. Further studies may
clarify in which situations BC offer true benefit to
the patient, in order to define more precisely its
use.
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